C. Wright Pinson

Learn More
Our goal was to evaluate fluorodeoxyglucose (FDG) positron emission tomography (PET) in staging patients with biliary tract cancers. Fifty consecutive patients who underwent FDG-PET for suspected cholangiocarcinoma (n = 36) or gallbladder carcinoma (n = 14) were reviewed. Patients with cholangiocarcinoma were divided into two groups: group 1 had nodular(More)
UNLABELLED Accurate detection of recurrent colorectal carcinoma remains a diagnostic challenge. The purposes of this study were to assess the accuracy of 18FDG-PET in patients with recurrent colorectal carcinoma in detecting liver metastases compared with computed tomography (CT) and CT portography, detecting extrahepatic metastases compared with CT and(More)
Cholangiocarcinoma presents a formidable diagnostic and treatment challenge. The majority of patients present with unresectable disease and have a survival of less than 12 months following diagnosis. Progress has been made by the appropriate selection of patients for treatment options including resection, with the routine use of more aggressive resections(More)
BACKGROUND In most malignant cells, the relatively low level of glucose-6-phosphatase leads to accumulation and trapping of [18F]fluorodeoxyglucose (FDG) intracellularly, allowing the visualization of increased uptake compared with normal cells. OBJECTIVES To assess the value of FDG positron emission tomography (PET) to differentiate benign from malignant(More)
OBJECTIVE Evaluate experience over 15 years with treatment of this lesion. SUMMARY BACKGROUND DATA Biliary cystadenoma, a benign hepatic tumor arising from Von Meyenberg complexes, usually present as septated intrahepatic cystic lesions. METHODS Data were collected concurrently and retrospectively on patients identified from hospital medical records(More)
BACKGROUND Accurate detection of recurrent colorectal carcinoma remains a clinical challenge. Positron emission tomography (PET) using 18F-fluorodeoxyglucose (18FDG) is an imaging technique that allows direct evaluation of cellular metabolism. 18F-fluorodeoxyglucose PET was compared to computed tomography (CT) and CT portography for staging metastatic(More)
BACKGROUND/AIMS Transjugular intrahepatic portosystemic shunt (TIPS) placement has been used for the treatment of recurrent variceal hemorrhage. The 1-year incidence of shunt stenosis or occlusion after TIPS placement was prospectively assessed, and the accuracy of Doppler ultrasonography to predict TIPS stenosis was evaluated. METHODS Twenty-two patients(More)
Tumors in the proximal third of the bile duct are associated with the lowest rates of resectability and poorest survival of tumors in all locations in the duct. Of 25 patients who underwent resection for tumors located proximally, 3 had extended right hepatic lobectomy, 6 had left hepatic lobectomy, and 16 had skeletonization resection. The operative(More)
The goals of treatment of the Budd-Chiari syndrome are relief of portal hypertension, relief of inferior vena cava syndrome, if present, and preservation of hepatic function. This study presents a patient with clinical resolution of the Budd-Chiari syndrome after placement of expandable metallic stents in the inferior vena cava and hepatic veins. A(More)
OBJECTIVE The authors addressed whether a repeat hepatic operation is warranted in patients with recurrent isolated hepatic metastases. Are the results as good after second operation as after first hepatic operation? SUMMARY BACKGROUND DATA Five-year survival after initial hepatic operation for colorectal metastases is approximately 33%. Because available(More)